Press Release: Eos acquires minority in pharma repackager

Eos Capital partners with Namibian Pharmaceutical manufacturer to establish major regional pharma player Eos Capital is pleased to announce that it has acquired 35% of the ordinary share capital of Fabupharm (Pty) Ltd, pending Namibian Competition Commission approval, with the aim of supporting Fabupharm in its ambition to become a major player in the Namibian…

Read More

Important note to SAVCA members on regulation and reporting: Automatic Exchange of Information: FATCA and OECD CRS

Automatic Exchange of Information: FATCA and OECD CRS The new SARS Business Requirement Specification (BRS) issued on 24 June 2016 is significantly different from the FATCA BRS that has been in existence for the past two reporting periods.  The following are important when completing the new submission to SARS: Mandatory indicators in the BRS include…

Read More